Projected Income Statement: Eramet

Forecast Balance Sheet: Eramet

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 936 344 614 1,297 1,935 1,477 1,759 1,608
Change - -63.25% 78.49% 111.24% 49.19% -23.67% 19.09% -8.58%
Announcement Date 2/23/22 A 2/22/23 A 2/21/24 A 2/19/25 A 2/18/26 A - - -
1EUR in Million
Estimates

Cash Flow Forecast: Eramet

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 312 530 920 602 429 287.5 320 317.5
Change - 69.87% 73.58% -34.57% -28.74% -32.98% 11.3% -0.78%
Free Cash Flow (FCF) 1 401 586 -465 -727 -742 -239.6 -36.3 52.05
Change - 46.13% -179.35% -56.34% -2.06% 67.7% 84.85% 243.39%
Announcement Date 2/23/22 A 2/22/23 A 2/21/24 A 2/19/25 A 2/18/26 A - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Eramet

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 28.65% 30.97% 10.67% 12.65% 13.51% 14.97% 20.21% 20.46%
EBIT Margin (%) 21.37% 25.53% 3.91% 3.31% 0.4% 8.01% 14% 12.55%
EBT Margin (%) 24.24% 23.81% 3.08% 1.43% -19.14% -7.66% 1.75% 3.78%
Net margin (%) 8.12% 14.76% 3.35% 0.48% -17.33% -9.19% 1.48% 3.09%
FCF margin (%) 10.93% 11.69% -14.3% -24.79% -26.95% -7.44% -1.01% 1.42%
FCF / Net Income (%) 134.56% 79.19% -426.61% -5,192.86% 155.56% 80.91% -68.24% 46.06%

Profitability

        
ROA - - - - - - - -
ROE 25.99% 50.96% 6.45% 0.92% -44.19% -33.23% 9.55% 10.75%

Financial Health

        
Leverage (Debt/EBITDA) 0.89x 0.22x 1.77x 3.5x 5.2x 3.06x 2.43x 2.15x
Debt / Free cash flow 2.33x 0.59x -1.32x -1.78x -2.61x -6.16x -48.44x 30.89x

Capital Intensity

        
CAPEX / Current Assets (%) 8.51% 10.57% 28.3% 20.53% 15.58% 8.92% 8.92% 8.68%
CAPEX / EBITDA (%) 29.69% 34.13% 265.13% 162.26% 115.32% 59.58% 44.13% 42.43%
CAPEX / FCF (%) 77.81% 90.44% -197.85% -82.81% -57.82% -119.97% -881.54% 609.99%

Items per share

        
Cash flow per share 1 24.93 38.92 8.327 -4.323 -10.94 1.12 10.6 16.78
Change - 56.13% -78.61% -151.92% -153.09% 110.24% 845.59% 58.36%
Dividend per Share 1 2.5 3.5 1.5 1.5 - - 0.25 0.5
Change - 40% -57.14% 0% - - - 100%
Book Value Per Share 1 38.1 61.34 55.28 50.57 25.19 27.8 23.91 31.95
Change - 60.96% -9.87% -8.52% -50.19% 10.36% -14.01% 33.63%
EPS 1 10.42 25.81 3.79 0.5 -16.67 -10.35 2.047 6.715
Change - 147.7% -85.32% -86.81% -3,434% 37.94% 119.79% 228.01%
Nbr of stocks (in thousands) 28,683 26,558 28,542 28,451 28,359 28,502 28,502 28,502
Announcement Date 2/23/22 A 2/22/23 A 2/21/24 A 2/19/25 A 2/18/26 A - - -
1EUR
Estimates
2026 *2027 *
P/E -4.39x 22.2x
PBR 1.64x 1.9x
EV / Sales 0.86x 0.85x
Yield - 0.55%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
45.46EUR
Average target price
51.00EUR
Spread / Average Target
+12.19%

Quarterly revenue - Rate of surprise